Ubs Group Ag Veru Inc. Call Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding VERU
# of Institutions
144Shares Held
46.2MCall Options Held
170KPut Options Held
2.25M-
Black Rock Inc. New York, NY7.65MShares$3.9 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA6.59MShares$3.36 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.25MShares$3.19 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$1.55 Million0.0% of portfolio
-
State Street Corp Boston, MA2.23MShares$1.14 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $40.9M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....